Synthesis and antiinflammatory activity of some new 1,3,5-trisubstituted pyrazolines bearing benzene sulfonamide

被引:159
作者
Rathish, I. G. [1 ]
Javed, Kalim [1 ]
Ahmad, Shamim [1 ]
Bano, Sameena [1 ]
Alam, M. S. [1 ]
Pillai, K. K. [2 ]
Singh, Surender [3 ]
Bagchi, Vivek [4 ]
机构
[1] Jamia Hamdard, Fac Sci, Dept Chem, New Delhi 110062, India
[2] Jamia Hamdard, Fac Pharm, Dept Pharmacol, New Delhi 110062, India
[3] All India Inst Med Sci, Dept Pharmacol, New Delhi 110029, India
[4] Indian Inst Technol, Dept Chem, New Delhi 110016, India
关键词
2-Pyrazolines; Celecoxib; Anti-inflammatory activity; COX-1; COX-2; SYNTHASE CYCLOOXYGENASE; DRUGS; INHIBITION;
D O I
10.1016/j.bmcl.2008.10.105
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
Nineteen new 2-pyrazoline bearing benzenesulfonamide derivatives were synthesized by condensing chalcones with 4-hydrazinonbenzenesulfonamide hydrochloride. Their chemical structures were proved by means of IR, H-1 NMR, C-13 NMR, mass spectroscopic and elemental analyses data. These compounds were tested at dose of 20 mg/kg for their anti-inflammatory activity in carrageenan-induced rat paw edema model and volume of paw edema was measured at 0, 3 and 5 h. Two compounds 3k and 3l were found to be more active than celecoxib throughout the study (at 3 and 5 h). While two other compounds 3m and 3n showed more potent activity than celecoxib at 5 h. They are devoid of ulcerogenic potential when administered orally at a dose of 60 mg/kg. Compounds (3k-m) showed COX-1 and COX-2 inhibitory activity at 0.05 mu M. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:255 / 258
页数:4
相关论文
共 11 条
[1]
AHLUWALIA VK, 2005, INTERMEDIATES ORGANI, P116
[2]
GASTROINTESTINAL DAMAGE ASSOCIATED WITH THE USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].
ALLISON, MC ;
HOWATSON, AG ;
TORRANCE, CJ ;
LEE, FD ;
RUSSELL, RI .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (11) :749-754
[3]
ANDOTRA CS, 1993, J INDIAN CHEM SOC, V70, P266
[4]
Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors [J].
de Gaetano, G ;
Donati, MB ;
Cerletti, C .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (05) :245-252
[5]
FU JY, 1990, J BIOL CHEM, V265, P16737
[6]
Kinetic basis for selective inhibition of cyclo-oxygenases [J].
Gierse, JK ;
Koboldt, CM ;
Walker, MC ;
Seibert, K ;
Isakson, PC .
BIOCHEMICAL JOURNAL, 1999, 339 :607-614
[7]
DETECTION AND ISOLATION OF AN ENDOPEROXIDE INTERMEDIATE IN PROSTAGLANDIN BIOSYNTHESIS [J].
HAMBERG, M ;
SAMUELSS.B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (03) :899-903
[8]
KHAN MSY, 1993, INDIAN J CHEM B, V32, P374
[9]
MEADE EA, 1993, J BIOL CHEM, V268, P6610
[10]
Prostaglandin endoperoxide H synthases-1 and -2 [J].
Smith, WL ;
Dewitt, DL .
ADVANCES IN IMMUNOLOGY, VOL 62, 1996, 62 :167-215